Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald L Denardo

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Year 2002: the best year yet for CB&RGerald L DeNardo, Robert K Oldham
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patientsGerald L DeNardo, Sally J DeNardo
Journal of Immunological Methods|February 28, 2006
Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibilityHuguette Albrecht, Gerald L Denardo, Sally J Denardo
Statistics in Medicine|June 7, 2006
On the analysis of count data of birth-and-death process type: with application to molecularly targeted cancer therapyHao Liu, Laurel A Beckett, Gerald L DeNardo
Cancer Biotherapy & Radiopharmaceuticals|September 6, 2008
Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?Gerald L DeNardo, Sally J DeNardo, Rod Balhorn
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Cure of incurable lymphomaGerald L DeNardo, Vladimir V Sysko, Sally J DeNardo
Medical Physics|August 14, 2008
Targeted radionuclide therapyLawrence E Williams, Gerald L DeNardo, Ruby F Meredith
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphomaMalik Juweid, Gerald L DeNardo, Michael Graham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapyChristine L Hartmann Siantar, Gerald L DeNardo, Sally J DeNardo
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograftLaird Miers, Sally J DeNardo, Kathleen Lamborn, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Year 2002: the best year yet for CB&RGerald L DeNardo, Robert K Oldham
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patientsGerald L DeNardo, Sally J DeNardo
Journal of Immunological Methods|February 28, 2006
Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibilityHuguette Albrecht, Gerald L Denardo, Sally J Denardo
Statistics in Medicine|June 7, 2006
On the analysis of count data of birth-and-death process type: with application to molecularly targeted cancer therapyHao Liu, Laurel A Beckett, Gerald L DeNardo
Cancer Biotherapy & Radiopharmaceuticals|September 6, 2008
Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?Gerald L DeNardo, Sally J DeNardo, Rod Balhorn
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Cure of incurable lymphomaGerald L DeNardo, Vladimir V Sysko, Sally J DeNardo
Medical Physics|August 14, 2008
Targeted radionuclide therapyLawrence E Williams, Gerald L DeNardo, Ruby F Meredith
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphomaMalik Juweid, Gerald L DeNardo, Michael Graham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapyChristine L Hartmann Siantar, Gerald L DeNardo, Sally J DeNardo
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograftLaird Miers, Sally J DeNardo, Kathleen Lamborn, et al.
Pageof 7